Answers are grounded in this paper and cite their sources.
Endothelial dysfunction is an early detectable pathological event in the development of atherosclerosis and high-fat diet is considered as a major modifiable risk factor that contributing to its development. Oxidized low-density lipoprotein (oxLDL) can promote endothelial dysfunction through inflammatory activation, oxidative stress, impaired endothelial homeostasis, and dysregulation of extracellular matrix (ECM) remodeling. Sesamol, a phenolic lignan derived from sesame (Sesamum indicum L.), has recognized antioxidant and anti-inflammatory properties; however, its protective effect against oxLDL-induced endothelial dysfunction has not been thoroughly studied. Primary rat aortic endothelial cells (RAOECs) were exposed to 50 μg/mL oxLDL, with or without sesamol (25 and 50 μM). In oxLDL-induced RAOECs, sesamol treatment resulted in the downregulation of LOX-1 mRNA levels and restoration of MnSOD expression. Sesamol also suppressed inflammatory activation of endothelial cells by decreasing TNF-α, IL-6, and iNOS protein levels and the mRNA levels of COX-2. Additionally, sesamol reduced sICAM-1, sVCAM-1 protein secretions and ET-1 mRNA expression while restoring the mRNA levels of eNOS and CD31, indicating preservation of endothelial homeostasis. Furthermore, sesamol improved extracellular matrix homeostasis by lowering the production and gelatinolytic activities of MMP-2 and MMP-9 and raising TIMP-1 and TIMP-2 protein levels. Mechanistically, sesamol increased SIRT1 mRNA expression and reduced acetylation of the NF-κB p65 subunit, suggesting that the anti-inflammatory effects of sesamol may involve modulation of SIRT1-associated NF-κB signaling.
No takes yet. Share an insight, caveat, or question.
Kazan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: